Open AccessOcular manifestation and generalization after ocular onset in ocular myasthenia gravis: A 5-year analysis
Author(s) -
Parinee Kemchoknatee,
Apisama Arepagorn,
Thansit Srisombut
Publication year - 2021
Publication title -
asian pacific journal of allergy and immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.405
H-Index - 33
ISSN - 0125-877X
DOI - 10.12932/ap-260521-1141
Subject(s) - ocular myasthenia , diplopia , ptosis , medicine , myasthenia gravis , hazard ratio , pediatrics , proportional hazards model , multivariate analysis , gastroenterology , surgery , confidence interval
Ocular Myasthenia Gravis (OMG) is an autoimmune disease which causes ptosis, diplopia, or both. There is very limited information on the presenting symptoms, treatment trends, factors influencing generalization, and treatment outcome in Thai populations.